CME vs PROF · P/E 22, rev $6.52B vs rev $10.7M
CME Group Inc (CME) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported CME revenue for 2025-12-31 was $6.52B. Net income was $4.07B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
CME currently screens at market cap $91.25B and trailing P/E 21.9. PROF currently screens at market cap $238.7M.
Not investment advice. Open the CME and PROF stock pages for the full models.
Not investment advice.